Abstract
Flow cytometry provides an automated analysis of bacteria passing in fluid suspension through a laser light beam. Bacteria are first treated with antibodies that bind to a specific target. These antibodies are tagged to fluorophores that fluoresce when passed through a laser beam. As the bacteria pass sequentially through the laser beam, they absorb and scatter the light in forward and side (90°) angles. The forward angle scatter is proportional to the size of the bacteria and the 90° angle side scatter is proportional to the internal structure (granularity). In addition, the tagged antibodies bound specifically to each bacteria, emit fluorescent light at defined wavelengths that can be collected and measured.
Here we describe two flow cytometry based assays to measure expression levels of protein and polysaccharide on the surface of Neisseria meningitidis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harris SL, Donald RG, Hawkins JC, Tan C, O’Neill R, McNeil LK, Perez JL, Anderson AS, Jansen KU, Jones TR (2017) Neisseria meningitidis serogroup B vaccine, Bivalent rLP2086, induces broad serum bactericidal activity against diverse invasive disease strains including outbreak strains. Pediatr Infect Dis J 36:216–223
Borrow R, Balmer P, Miller E (2005) Meningococcal surrogates of protection – serum bactericidal antibody activity. Vaccine 23:2222–2227
Frasch CE, Borrow R, Donnelly J (2009) Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine 27(Suppl 2):B112–B116
McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS (2018) Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by Bivalent rLP2086, a novel prophylactic vaccine. MBio 9. https://doi.org/10.1128/mBio.00036-18
Borrow R, Findlow J, Gray S, Taylor S, Kaczmarski E (2014) Safe laboratory handling of Neisseria meningitidis. J Infect 68:305–312
Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR, Centers for Disease Control (2015) Use of serogroup B meningococcal vaccines in persons aged >/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep 64:608–612
Acknowledgments
This work was supported by Pfizer.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Loschko, J., Garcia, K., Cooper, D., Pride, M., Anderson, A. (2019). Flow Cytometric Assays to Quantify fHbp Expression and Detect Serotype Specific Capsular Polysaccharides on Neisseria meningitidis. In: Seib, K., Peak, I. (eds) Neisseria meningitidis. Methods in Molecular Biology, vol 1969. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9202-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9202-7_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9201-0
Online ISBN: 978-1-4939-9202-7
eBook Packages: Springer Protocols